Management of Elevated Dihydrotestosterone with Normal Testosterone Levels

Monitoring and Treatment

• Baseline and follow-up assessments should include PSA and digital rectal examination to monitor prostate health, hematocrit or hemoglobin levels, lipid evaluation, and assessment of voiding symptoms, as recommended by the American College of Physicians 1
• Follow-up schedule should include first follow-up at 1-2 months to assess efficacy, subsequent monitoring at 3-6 month intervals for the first year, and yearly monitoring thereafter, according to the American Academy of Family Physicians 1
• Men interested in fertility should undergo reproductive health evaluation prior to treatment, as suggested by the American Urological Association 4
• The American College of Physicians recommends that 5α-reductase inhibitors be used with caution in men actively trying to conceive 2
• Lifestyle modifications such as weight loss and increased physical activity may help normalize hormone levels, as recommended by the European Association of Urology 3
• The American Urological Association suggests that monitoring without pharmacological intervention may be appropriate if DHT elevation is mild and asymptomatic 1
• Regular monitoring of PSA and prostate symptoms is essential during treatment, and any abnormal findings warrant urological evaluation, as recommended by the American College of Physicians 1
• Endocrinology referral is warranted if DHT elevation is accompanied by other hormonal abnormalities, according to the Endocrine Society 4
• Urology referral is appropriate for significant lower urinary tract symptoms, abnormal digital rectal examination or elevated PSA, and concerns about prostate health, as recommended by the American Urological Association [1] [5]